H.C. Wainwright cuts Oric Pharmaceuticals target price to $20 from $27
ORIC•H.C. Wainwright cut its target price for Oric Pharmaceuticals to $20 from $27.
Related News

Accenture launches plan to cut 950 Meta-linked jobs in Portugal
ACN•

Orlen, Carlyle sign MoU on joint energy investments
CG•

Compass Pathways participates in 9th annual Evercore Healthcare Conference
CMPS•

The 'AI dollar' has arrived. Its direction hasn't: Mike Dolan
TLT•

HF Sinclair names Shawn J. Carsten CFO, effective Jan. 1, 2027
DINO•